Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Experimental Dermatology|December 1, 2019
Blockade of CCR5 in melanoma: An alternative immune checkpoint modulatorJulia Escandon Brehm, Barbara Bedogni
Pediatric Dermatology|January 7, 2021
Acute urticaria preceding other COVID-19-associated manifestations-A case reportVivien Chen, Julia Escandon Brehm, Fernanda Bellodi Schmidt
American Journal of Otolaryngology|April 16, 2010
Refractory erythromelalgia of the ears: response to mexiletineAlejandra C Vivas, Julia Escandon, Robert S Kirsner
Plastic and Reconstructive Surgery|January 5, 2011
State of the art in topical wound-healing productsKenneth Fan, Jennifer Tang, Julia Escandon, et al.
The Journal of Clinical and Aesthetic Dermatology|July 19, 2012
Presentation of reticulate acropigmentation of kitamura and dowling-degos disease overlapJennifer C Tang, Julia Escandon, Michael Shiman, et al.
Methods in Molecular Biology (Clifton, N.J.)|July 20, 2016
Isolation of Mouse Hair Follicle Bulge Stem Cells and Their Functional Analysis in a Reconstitution AssayYing Zheng, Jen-Chih Hsieh, Julia Escandon, et al.
Journal of Drugs in Dermatology : JDD|May 3, 2021
A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm Treated With a Bcl-2 InhibitorAndjela Egger, Diana Coello, Robert S Kirsner, et al.
International Wound Journal|February 3, 2012
A prospective pilot study of ultrasound therapy effectiveness in refractory venous leg ulcersJulia Escandon, Alejandra C Vivas, Robert Perez, et al.
Surgical Technology International|July 29, 2016
Aneuploidy and Tetraploidy as Distinct Patterns During MelanomagenesisJulia Escandon, Lauren King, Reuven Blobstein, et al.
Journal for Immunotherapy of Cancer|January 21, 2017
Interstitial nephritis in melanoma patients secondary to PD-1 checkpoint inhibitorJulia Escandon, Stephanie Peacock, Asaad Trabolsi, et al.
Pageof 2